Reduction in C3, C4 and CH50 levels is well described in SLE, and has earlier been inversely associated with rising levels of dsDNA antibodies.39 40 Our results could be a reflection of a subgroup of patients’ genetic predisposition to produce anti-dsDNA antibodies, subsequent formation of immune complexes and complement consumption. Here, C3 is linked to systemic lupus erythematosus.